Life Sciences Medical Device Traceability
Track and trace medical devices with Cognex technology
The United States Food and Drug Administration (FDA) Unique Device Identifier (UDI) mandate and the European Commission Medical Device and In Vitro Diagnostic Regulations (MDR/IVDR) require the use of UDI markings to track and trace medical devices from manufacturing to hospitals. After the marking or label printing process, codes can be low contrast or damaged, recessed, marked on shiny or white surfaces, or printed under shrink-wrap that makes them hard to read. This can result in delayed production, scrappage, and patient safety concerns.
The Cognex AE2 Advantage engine with DataMan software leverages the power of Cognex vision and barcode reading tools in an embedded product that is compact and flexible, but also cost-effective. It includes an easy-to-integrate form factor and open software architecture and interfaces. The Advantage engine delivers best-in-class 1D and 2D code reading for traceability, plus a full suite of industry-proven vision tools to locate, analyze, and inspect parts or features for embedded vision applications.